EW EDWARDS LIFESCIENCES CORP revenue, earnings and financials

For the quarter ended June 30, 2026, EDWARDS LIFESCIENCES CORP reported revenue of $1.74B (up 13.6% from a year earlier), net income of $242M and diluted EPS of $0.42; over the last four quarters revenue was $6.51B and net income $1.00B; for the fiscal year ended December 2025 revenue was $6.07B, up 11.5% on the year before.

EW annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $6.07B, gross profit $4.73B, operating income $1.26B, net income $1.07B (margin 17.7%), EPS $1.83
• Fiscal year ended Dec 2024: revenue $5.44B, gross profit $4.32B, operating income $1.38B, net income $4.17B (margin 76.7%), EPS $6.97
• Fiscal year ended Dec 2023: revenue $5.01B, gross profit $4.03B, operating income $1.31B, net income $1.40B (margin 28.0%), EPS $2.30
• Fiscal year ended Dec 2022: revenue $4.46B, gross profit $3.74B, operating income $1.50B, net income $1.52B (margin 34.1%), EPS $2.44
• Fiscal year ended Dec 2021: revenue $5.23B, gross profit $3.98B, operating income $1.69B, net income $1.50B (margin 28.7%), EPS $2.38

EW quarterly revenue and earnings

• Quarter ended Jun 30, 2026: revenue $1.74B (up 13.6% year over year), net income $242M, EPS $0.42
• Quarter ended Mar 31, 2026: revenue $1.65B (up 16.7% year over year), net income $381M, EPS $0.66
• Quarter ended Dec 31, 2025 (from the annual report): revenue $1.57B (up 13.3% year over year), net income $91.2M, EPS $0.16
• Quarter ended Sep 30, 2025: revenue $1.55B (up 14.7% year over year), net income $291M, EPS $0.50
• Quarter ended Jun 30, 2025: revenue $1.53B (up 11.9% year over year), net income $333M, EPS $0.56
• Quarter ended Mar 31, 2025: revenue $1.41B (up 6.2% year over year), net income $358M, EPS $0.61
• Quarter ended Dec 31, 2024: revenue $1.39B (up 9.4% year over year), net income $386M, EPS $0.65
• Quarter ended Sep 30, 2024: revenue $1.35B (up 8.9% year over year), net income $3.07B, EPS $5.13
• Quarter ended Jun 30, 2024: revenue $1.37B (up 7.1% year over year), net income $366M, EPS $0.61
• Quarter ended Mar 31, 2024: revenue $1.33B (up 8.9% year over year), net income $352M, EPS $0.58
• Quarter ended Dec 31, 2023: revenue $1.27B (up 194.6% year over year), net income $370M, EPS $0.61
• Quarter ended Sep 30, 2023: revenue $1.24B (down 5.7% year over year), net income $385M, EPS $0.63
• Quarter ended Jun 30, 2023: revenue $1.28B (down 6.9% year over year), net income $307M, EPS $0.50
• Quarter ended Mar 31, 2023: revenue $1.22B (down 8.9% year over year), net income $341M, EPS $0.56
• Quarter ended Dec 31, 2022 (from the annual report): revenue $430M (down 67.7% year over year), net income $398M, EPS $0.65
• Quarter ended Sep 30, 2022: revenue $1.32B (up 0.7% year over year), net income $344M, EPS $0.55
• Quarter ended Jun 30, 2022: revenue $1.37B (down 0.2% year over year), net income $406M, EPS $0.65
• Quarter ended Mar 31, 2022: revenue $1.34B (up 10.2% year over year), net income $374M, EPS $0.59
• Quarter ended Dec 31, 2021 (from the annual report): revenue $1.33B, net income n/a, EPS $0.52
• Quarter ended Sep 30, 2021: revenue $1.31B, net income n/a, EPS $0.54

EW cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow $1.60B, share buybacks $893M
• Fiscal year ended Dec 2024: operating cash flow $542M, share buybacks $1.16B
• Fiscal year ended Dec 2023: operating cash flow $896M, share buybacks $880M
• Fiscal year ended Dec 2022: operating cash flow $1.22B, share buybacks $1.73B
• Fiscal year ended Dec 2021: operating cash flow $1.73B, share buybacks $513M

EW balance sheet

• Jun 30, 2026: cash $2.91B, total assets $13.9B, total liabilities $3.14B, shareholders' equity $10.6B, long-term debt $599M
• Mar 31, 2026: cash $2.45B, total assets $13.3B, total liabilities $2.99B, shareholders' equity $10.3B, long-term debt $599M
• Dec 31, 2025: cash $2.94B, total assets $13.7B, total liabilities $3.36B, shareholders' equity $10.3B, long-term debt $598M
• Sep 30, 2025: cash $2.69B, total assets $13.3B, total liabilities $3.07B, shareholders' equity $10.2B, long-term debt $598M
• Jun 30, 2025: cash $3.27B, total assets $13.5B, total liabilities $2.88B, shareholders' equity $10.5B, long-term debt $598M
• Mar 31, 2025: cash $3.14B, total assets $13.0B, total liabilities $2.83B, shareholders' equity $10.1B, long-term debt $598M
• Dec 31, 2024: cash $3.05B, total assets $13.1B, total liabilities $2.99B, shareholders' equity $10.00B, long-term debt $598M
• Sep 30, 2024: cash $3.68B, total assets $13.0B, total liabilities $3.36B, shareholders' equity $9.55B, long-term debt $598M

What is EW's revenue?

EDWARDS LIFESCIENCES CORP reported $6.51B of revenue over its last four quarters, through June 30, 2026.

Is EW profitable?

Yes. EDWARDS LIFESCIENCES CORP earned $1.00B over the last four quarters.

What is EW's EPS?

Diluted earnings per share over the last four quarters were $1.74; $0.42 in the latest quarter.

EW ownership and insider trades · All stocks